惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

D
DataBreaches.Net
V
Vulnerabilities – Threatpost
C
CERT Recently Published Vulnerability Notes
Google DeepMind News
Google DeepMind News
GbyAI
GbyAI
Y
Y Combinator Blog
T
Threatpost
Threat Intelligence Blog | Flashpoint
Threat Intelligence Blog | Flashpoint
Project Zero
Project Zero
Engineering at Meta
Engineering at Meta
MongoDB | Blog
MongoDB | Blog
MyScale Blog
MyScale Blog
Security Latest
Security Latest
T
Threat Research - Cisco Blogs
量子位
I
Intezer
Simon Willison's Weblog
Simon Willison's Weblog
C
Cybersecurity and Infrastructure Security Agency CISA
L
Lohrmann on Cybersecurity
L
LINUX DO - 最新话题
The Register - Security
The Register - Security
T
Tailwind CSS Blog
爱范儿
爱范儿
Google DeepMind News
Google DeepMind News
T
Troy Hunt's Blog
Stack Overflow Blog
Stack Overflow Blog
Cloudbric
Cloudbric
S
Secure Thoughts
The GitHub Blog
The GitHub Blog
T
The Blog of Author Tim Ferriss
L
LangChain Blog
Recorded Future
Recorded Future
小众软件
小众软件
www.infosecurity-magazine.com
www.infosecurity-magazine.com
T
Tor Project blog
人人都是产品经理
人人都是产品经理
F
Full Disclosure
O
OpenAI News
Webroot Blog
Webroot Blog
A
Arctic Wolf
TaoSecurity Blog
TaoSecurity Blog
P
Privacy & Cybersecurity Law Blog
Jina AI
Jina AI
Cyber Security Advisories - MS-ISAC
Cyber Security Advisories - MS-ISAC
Exploit-DB.com RSS Feed
Exploit-DB.com RSS Feed
雷峰网
雷峰网
Microsoft Security Blog
Microsoft Security Blog
H
Heimdal Security Blog
B
Blog RSS Feed
Vercel News
Vercel News

Pulse News | The HinduBusinessLine

Mission universal access to clean energy Canada invests in building climate-resilient health systems Hidden hunger: Fixing the micronutrient crisis Honour the calling, rebuild trust in healthcare Self-reliant well-being When patients fall through the cracks of health insurance claims ‘The kindergarten health class for the 50-plus’ Tennis, sustainable meals and painting NFHS-6: Obesity scale tilts heavily against women Yoga for healthy ageing Medical negligence: A fair redressal system can restore trust Fragile success of HIV response UK sandbox for AI health innovations It’s time to revise the list of essential medicines Blood donation: Humanity in every drop How PMOS pushed this student to grow her own food USFDA moots ways to reduce animal testing for cancer drugs South Africa cracks down on illegal weight-loss drugs Morning walks, home food and no devices at dinner time E-pharmacies: The missing regulatory prescription Domestic drugmakers make a play for the innovation league Gatekeeping unproven ‘harm reduction’ nicotine products Unmasking tobacco’s appeal Repurposing medicines to treat more diseases Workouts, walking, and boundaries... not burnouts Fast-tracking biopharma goals with regulatory reform Making vaccines in and for Africa Medical ethics: The perils of not speaking up Keeping infant formula free of contaminants The ‘public health crisis’ facing transgender people UK busts criminal ring supplying illegal steroids Clean hands are life-saving Cardio sessions, cricket and unwinding with music ‘Free markets’ and shackled access to medicines Inside India’s GLP-1 rush Stalling the silent spread of TB cases Meditation, play and staying curious Towards a malaria-free future Don’t hide unfavourable clinical trial results: FDA Countries take more ownership of immunisation Medical supply chain leaks: Where does the buck stop? Stand with science for universal wellbeing Wearable tech: Health monitors on the go The uncomfortable conversations over end-of-life decisions USEPA labels microplastics, pharmaceuticals as contaminants How medical myths go viral at deadly speed Gym sessions, yoga and occasional return to rollerblading Australia looks for improved ways to regulate sunscreens Slower pace of reduction in child mortality India’s silent newborn crisis Small daily habits, no quick fixes TB endgame: Yes, we can Alternatives to animal testing in drug development The pothole ‘miracle’ that wasn’t ‘Special 301’ report, in a time of strife Chile ends leprosy — a first in the Americas Hydration, protein, and AI as pocket nutritionist Making the shift to vaccinating older people Citizen-led Canadian health strategy for men and boys What women want... from health insurance Investing in women’s wellbeing beyond maternity Kidney health and planet protection Where a hospital grew from the people Aloe vera, consistent workouts, ashwagandha and magnesium More cataract surgeries needed: WHO Quality summit for the pharma industry Digital addiction: The elephant in the living room Sending medicines via the India-US trade corridor UK medical device testing hits a high BioAsia lifesciences conclave Notes of inspiration, meditation, and light kickboxing Pre-check pilot to boost local pharma manufacturing in the US Custom waiver alone cannot make medicines affordable Batting for clinical trials, but not without its ‘subjects’ WHO calls for strong cancer prevention strategies Delivering self-care over the counter Greying Kerala’s rising tide of elder care needs and health support 'Rare diseases in India aren’t rare, they’re orphaned' Indian pharma seeks R&D booster shot to stay globally competitive Quiet lakeside walks, seasonal food, and cricket Labelling info on gluten-containing grains Harmful sugary drinks are not taxed enough: WHO Budget 2026 Why research no longer needs animal cruelty The rising climate toll on body and mind Walks, vegan food and crosswords Dangers of buying illegal weight-loss drugs online Data gap hinders FDA’s safety review of cosmetics Young brigade rises in India’s pharma sector Leprosy is curable, break the stigma Fragile peace between hospitals and insurance providers Testing times loom for the ‘pharmacy of the developing world’ Medical tourism: Pitching India’s cost and care advantage Restorative eating, music for reflection, and treadmill time Mapping how everyday medicines affect gut bacteria WHO launches digital library on traditional medicine Challenges ahead in 2026 Coldrif case: When cough syrup turns poison Tackling India’s future, complex disease burden How to make health insurance truly inclusive for people with disabilities
Fertility Inc: Inside India’s booming IVF business
2026-01-08 · via Pulse News | The HinduBusinessLine

“I have never seen two pink lines (in the pregnancy test kit) in my life and I’ve started feeling something is wrong with me though all medical reports are clear with both of us,” says 33 year old Sahana*, trying to conceive for five years.

“Every transfer and every egg collection, we get emotionally invested into the process on top of the financial strain,” says Jhansi (35)*. “We talk to our embryos, put their pictures around the house. We give them names. We cry when we watch the videos of them developing... but when another IVF failed, I cried…”

These emotional whiplashes sit at the heart of India’s booming IVF industry, where couples grapple with hope and disappointment, and no guaranteed outcomes.

India has 2,616 registered IVF clinics as of Dec 13, 2025, according to the National ART & Surrogacy Registry. Less than ten are government-run centres – that are priced lower or free. Tamil Nadu, with one of India’s lowest Total fertility Rate (at 1.3, below the replacement rate of 2.1), has 669 clinics, followed by Gujarat (357) and Telangana (276).

In fact, private IVF chains are expanding aggressively across smaller towns – from Hosur to Erode to Gorakhpur, often marketed with glossy promises — AI-driven embryo selection, home-based IVF cycles, “needle-free” injections, etc.

“A lot of what is portrayed as innovation — home IVF, boutique packages — is really just tailoring according to what patient wants,” says Dr Shery Angel, obstetrician and gynaecologist at Chettinad Hospital and Research Institute.

The core procedure however, remains the same, she explains: stimulate ovaries, retrieve eggs, fertilise them in the lab, grow the embryos for a few days and transfer few into the uterus.

Pushed by stigma and lack of awareness about assisted reproductive methods, many couples reach this stage late when simpler interventions such as follicular stimulation, lifestyle changes or Intrauterine Insemination (IUI) might once have worked.

For many hopeful of having a baby, the financial stress comes long before the psychological toll of waiting. Doctors say ₹1.5–3 lakh is charged per IVF cycle and most couples go through 2-3 cycles or more. Medicines, add-ons or any abnormalities push costs up by few more lakhs.

Negotiating insurance

Insurance brokers say nearly 90 percent of couples undergoing IVF face ‘catastrophic’ expenditure. “India performs roughly 2–2.5 lakh IVF cycles a year,” says Narendra Bharindwal, President of the Insurance Brokers Association of India. “But only about 5 per cent have any insurance support, and even that is restrictive.”

The IVF market grows at 15-20 percent annually, he says, and demand for coverage is “small but clearly rising,” especially in sectors like IT, consulting, GCCs. And yet, he adds, “IVF is high-ticket, procedure-based and time-bound, so actuarial pricing and anti-selection concerns are sharper. That is why we are seeing cautious, capped benefits.”

In this vacuum, clinics now sell their own quasi-insurance products. In Yellow IVF’s Yellow Contract, couples booking two IVF cycles for ₹2.1 lakh are assured that if both cycles are unsuccessful, they will pay only ₹50,000 from the third cycle, regardless of actual cost.

While financial innovations seem reassuring, they exist almost entirely outside the Assisted Reproductive Technology (Regulation) Act, 2021, (ART Act), say industry experts.

Clinics / service players : Jindal IVF, Birla Fertility & IVF, Indira IVF, Seeds of Innocens, Yellow IVF; Milann Fertility and Birthing Hospital, GyKnow Medicare Centre; DSS Imagetech’s IVF vertical — Hanahealth, offering specialised IVF /ART services and products; IntegriMedical’s needle-free injection system used in IVF treatments etc.

Going rural

Dr Gauri Agarwal, founder, Seeds of Innocens IVF, which launched a home-based IVF model recently, says, they are seeing growing demand from smaller towns and rural areas where their model is helping overcome barriers of distance and stigma.

But the burgeoning industry comes with some concerns - including the sensitive gender question. Some couples recount hearsay of acquaintances “trying for a boy” through IVF, and published research from countries such as China, Australia and New Zealand has documented male-skewed IVF births.

“Scientifically, sex can be known at the embryo stage during PGT (Pre-implantation genetic testing), but in India it is completely illegal except for rare genetic reasons — where a couple carries a disease that affects only one sex. Only in those cases do we look at gender. Otherwise, it is not allowed,” says Dr Shery.

Existing regulatory frameworks offer little oversight in terms of tracking IVF sex ratios, success rates, costly add-ons and insurance coverage as the industry grows, observe industry-watchers.

Bharindwal calls for targeted policy – where the insurance regulator, for example, could issue guidelines on infertility and ART coverage (what can be covered / excluded, number of cycles, packages with out-patient components and minimum quality standards for empanelled clinics in line with the ART Act) – providing some cushion for couples.

The fertility factor

The fertility factor also often plays into the discussion on ART.

In developed western countries, economists attribute the fall in fertility rate to the lost opportunity costs for women who temporarily or permanently have to withdraw from the workforce to have children..

In India, though, the factors are varied and complex, say observers.

“Lack of proper diet, increase in stress, no proper workout or sleep are the main culprits. These cause blocks in fallopian tubes and increasing cases of resistant varieties of polycystic ovaries that don’t respond to treatment. All these pushes people to IVF,” says Dr Shery, giving a medical explanation to the growing reliance on IVF.

In fact, according to a recent analysis by Data for India, India’s female labour force participation rate is abysmally low at 31.58 per cent (Vietnam 75.74 per cent). Meaning, most adult women in India don’t work for pay outside the home, while most women in East Asia or Europe do. Yet, birth rates in India (1.99) are comparable to those in Vietnam (1.93) now, for example - indicating that a fertility rate that is stabilising in India has an explanation beyond growing career opportunities.

In After the Spike: Population, Progress and the Case for People, economists Dean Spears and Michael Geruso argue that fertility is falling not only because of economic pressures but because life itself has improved. As living standards rise, people place greater value on time, leisure and personal well-being. As these “nice things” expand, so does the opportunity cost of giving them up.

*(names changed to protect the identity of the individuals)

More Like This

A fertility procedure is displayed on a screen as a woman in scrubs monitors the process in a laboratory.

Published on December 15, 2025